
Lei Yao
Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1328 |
| Issued Applications | 662 |
| Pending Applications | 127 |
| Abandoned Applications | 552 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8675679
[patent_doc_number] => 08383793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/761050
[patent_app_country] => US
[patent_app_date] => 2010-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 39365
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12761050
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/761050 | Methods and compositions for the diagnosis and treatment of cancer resistant to anaplastic lymphoma kinase (ALK) kinase inhibitors | Apr 14, 2010 | Issued |
Array
(
[id] => 6273170
[patent_doc_number] => 20100255514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'TUMOR CELL-DERIVED MICROVESICLES'
[patent_app_type] => utility
[patent_app_number] => 12/759378
[patent_app_country] => US
[patent_app_date] => 2010-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 14616
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20100255514.pdf
[firstpage_image] =>[orig_patent_app_number] => 12759378
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/759378 | TUMOR CELL-DERIVED MICROVESICLES | Apr 12, 2010 | Abandoned |
Array
(
[id] => 6498531
[patent_doc_number] => 20100286179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'EGFR POLYMORPHISMS PREDICT GENDER-RELATED TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/758763
[patent_app_country] => US
[patent_app_date] => 2010-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26281
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12758763
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/758763 | EGFR polymorphisms predict gender-related treatment | Apr 11, 2010 | Issued |
Array
(
[id] => 6339300
[patent_doc_number] => 20100247438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/731499
[patent_app_country] => US
[patent_app_date] => 2010-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5200
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247438.pdf
[firstpage_image] =>[orig_patent_app_number] => 12731499
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/731499 | IN VITRO METHOD FOR DIAGNOSING TUMOR DISEASES | Mar 24, 2010 | Abandoned |
Array
(
[id] => 6433782
[patent_doc_number] => 20100278821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/730862
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 28294
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278821.pdf
[firstpage_image] =>[orig_patent_app_number] => 12730862
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/730862 | N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY | Mar 23, 2010 | Abandoned |
Array
(
[id] => 7489657
[patent_doc_number] => 08029981
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-04
[patent_title] => 'Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma'
[patent_app_type] => utility
[patent_app_number] => 12/726964
[patent_app_country] => US
[patent_app_date] => 2010-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20821
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/029/08029981.pdf
[firstpage_image] =>[orig_patent_app_number] => 12726964
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/726964 | Hypoxia-inducible protein 2 (HIG2), a diagnostic marker for clear cell renal cell carcinoma | Mar 17, 2010 | Issued |
Array
(
[id] => 6513789
[patent_doc_number] => 20100216696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Compounds and methods for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 12/661356
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18370
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216696.pdf
[firstpage_image] =>[orig_patent_app_number] => 12661356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/661356 | Compounds and methods for treating cancer | Mar 15, 2010 | Issued |
Array
(
[id] => 6513789
[patent_doc_number] => 20100216696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Compounds and methods for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 12/661356
[patent_app_country] => US
[patent_app_date] => 2010-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 18370
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216696.pdf
[firstpage_image] =>[orig_patent_app_number] => 12661356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/661356 | Compounds and methods for treating cancer | Mar 15, 2010 | Issued |
| 12/661314 | Compounds and methods for treating cancer | Mar 14, 2010 | Abandoned |
Array
(
[id] => 6095445
[patent_doc_number] => 20110002978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/721125
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15809
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20110002978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12721125
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/721125 | ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR CELLS OR TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF | Mar 9, 2010 | Abandoned |
Array
(
[id] => 6580961
[patent_doc_number] => 20100291068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/719554
[patent_app_country] => US
[patent_app_date] => 2010-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38605
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291068.pdf
[firstpage_image] =>[orig_patent_app_number] => 12719554
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/719554 | NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER | Mar 7, 2010 | Abandoned |
Array
(
[id] => 8158435
[patent_doc_number] => 20120100144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'Biomarker and Treatment for Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/254127
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15968
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100144.pdf
[firstpage_image] =>[orig_patent_app_number] => 13254127
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/254127 | Biomarker and Treatment for Cancer | Mar 1, 2010 | Abandoned |
Array
(
[id] => 8477754
[patent_doc_number] => 20120277161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'INHIBITION OF MULTIPLE CELL ACTIVATION PATHWAYS'
[patent_app_type] => utility
[patent_app_number] => 13/202843
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23429
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202843
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202843 | INHIBITION OF MULTIPLE CELL ACTIVATION PATHWAYS | Feb 22, 2010 | Abandoned |
Array
(
[id] => 7807248
[patent_doc_number] => 20120058202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'Means and Method for Ovarian Cancer Prognosis'
[patent_app_type] => utility
[patent_app_number] => 13/201740
[patent_app_country] => US
[patent_app_date] => 2010-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 31744
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058202.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201740 | Means and Method for Ovarian Cancer Prognosis | Feb 15, 2010 | Abandoned |
Array
(
[id] => 8701377
[patent_doc_number] => 08394598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Tyrosine kinome'
[patent_app_type] => utility
[patent_app_number] => 12/705760
[patent_app_country] => US
[patent_app_date] => 2010-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 4943
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12705760
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/705760 | Tyrosine kinome | Feb 14, 2010 | Issued |
Array
(
[id] => 6519156
[patent_doc_number] => 20100203054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'Wnt Proteins and Detection and Treatment of Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/701425
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20909
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20100203054.pdf
[firstpage_image] =>[orig_patent_app_number] => 12701425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/701425 | Wnt Proteins and Detection and Treatment of Cancer | Feb 4, 2010 | Abandoned |
Array
(
[id] => 6262871
[patent_doc_number] => 20100297158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'ANTICANCER VACCINE AND DIAGNOSTIC METHODS AND REAGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/698822
[patent_app_country] => US
[patent_app_date] => 2010-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12545
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297158.pdf
[firstpage_image] =>[orig_patent_app_number] => 12698822
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/698822 | Anticancer vaccine and diagnostic methods and reagents | Feb 1, 2010 | Issued |
Array
(
[id] => 6632054
[patent_doc_number] => 20100173341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'APOPTOSIS-BASED EVALUATION OF CHEMOSENSITIVITY IN CANCER PATIENTS'
[patent_app_type] => utility
[patent_app_number] => 12/689761
[patent_app_country] => US
[patent_app_date] => 2010-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6736
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173341.pdf
[firstpage_image] =>[orig_patent_app_number] => 12689761
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/689761 | APOPTOSIS-BASED EVALUATION OF CHEMOSENSITIVITY IN CANCER PATIENTS | Jan 18, 2010 | Abandoned |
Array
(
[id] => 6631766
[patent_doc_number] => 20100173314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/688363
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13804
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173314.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688363
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688363 | DIAGNOSTIC METHODS USING TENASCIN-W COMPOSITIONS | Jan 14, 2010 | Abandoned |
Array
(
[id] => 6232067
[patent_doc_number] => 20100184843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/683927
[patent_app_country] => US
[patent_app_date] => 2010-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 30817
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184843.pdf
[firstpage_image] =>[orig_patent_app_number] => 12683927
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/683927 | IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER | Jan 6, 2010 | Abandoned |